Announcements Trials
Browse Landscape

Phase

Phase NA 24Phase 4 5Phase 3 4Phase 2 3Phase 2/3 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1

Conditions

Rectal Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Oxaliplatin 49Fluorouracil 46Capecitabine 41Cisplatin 36Gemcitabine 29Leucovorin 27Bevacizumab 21Drug Therapy 20Paclitaxel 15Folfox protocol 15Radiotherapy 14Irinotecan 14apatinib 11Neoadjuvant Therapy 11Docetaxel 11sintilimab 9S 1 (combination) 9Sorafenib 8Nivolumab 8Trastuzumab 7Surgical Procedures, Operative 7Magnetic Resonance Spectroscopy 7lenvatinib 6atezolizumab 6XELOX 6Cetuximab 6Albumin-Bound Paclitaxel 6130-nm albumin-bound paclitaxel 6tislelizumab 5pembrolizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Control Groups × Gastrointestinal × Clear all
NCT07505472 2026-04-01

STARS-RC10

The First Hospital of Jilin University

Phase 2/3 Recruiting
212 enrolled
Gastrointestinal

Rectal Neoplasms

NCT05065957 2025-04-30

Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer

InnoPharmax Inc.

Phase 2/3 Recruiting
180 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡